Investor Presentaiton

II Introduction to the Company Ibnsina Pharma, Egypt's fastest growing pharmaceutical distributor... Company Overview Established in 2001, Ibnsina Pharma “ISP” is the fastest growing, and 2nd largest, pharmaceutical distributor in Egypt with a market share of 21.3% Nationwide distribution network with 62 operational sites including distribution hubs and central warehouses, supported by a fleet of c.761 vehicles serving c.42k retail pharmacies, hospitals & wholesalers across Egypt Pioneer in introducing value added services for its customers including telesales, same-day-delivery and creative commercial activities, in addition to third party logistics services for its suppliers including; warehousing, transportation, data analytics, packaging and relabeling, and quarantine inspections Shareholding Structure 1 Market Share¹ 21.3% 2013 11.5% FY19 ibnsinapharma Key Suppliers Key Financial Highlights EBRD 8.7% Faisal Islamic Bank Abdel Gawad 12.6% & Family Senior novo nordisk 13.5% Mgmt & Others 5.2% NOVARTIS gsk Gross Revenue² & GPM | EGP mn, % EBITDA & Margin | EGP mn, % Abbott SERVIER ANOFI Pfizer 7.20% 7.30% 7.90% 8.62% 8.40% 8.44% 16,941 2.9% 2.9% 3.2% 4.2% 4.2% 4.2% 750 13,678 554 Mahgoub Group 13.0% AIKMA 9,818 406 PHARCO EVAPHARMA AMOUN 7,372 QUALITY CORPORATION 5,439 229 Securing Your Health 4,302 Free 122 155 Float 47.0% EIPICO GNP AstraZeneca Quality Organization Standardization ISO XTX 9001:2015 ibnsinapharma 2014 2015 2016 2017 2018 2019 2014 2015 2016 2017 2018 2019 Certifications Net Profit & Margin | EGP mn, % ROE % Environmental Road Safety Health & Safety Internatio onal Organization ISO 1.8% 2.0% 2.0% 328 47% Standa 1.4% 263 36% ISO OHSAS 1.1% 32% 33% 0.9% 170 102 38 57 18001:2007 14001:2015 39001 2014 2015 2016 2017 2018 2019 (1) Post IPO & Capital Increase; (2) Pro forma gross revenue includes part of 3PL revenue that was stated as other income until 2016 Source: IMS Health, Company Management 27% 27% 2014 2015 2016 2017 2018 2019 5

View entire presentation